ScreenerHero

LH Labcorp Holdings Inc.

NYSE · US · Healthcare · Diagnostics & Research · labcorp.com
311.28USD+0.85%Mkt Cap: 25.03B $P/E: 25.53

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, bloo…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
DHR
Danaher Corporation
$155.51BUSDP/E 39.4
NTRA
Natera, Inc.
$61.35BUSD
LONN
Lonza Group AG
$45.82BUSDP/E 38.1
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
ILMN
Illumina, Inc.
$44.35BUSDP/E 54.8
IQV
IQVIA Holdings Inc.
$43.80BUSDP/E 33.1
WAT
Waters Corporation
$43.21BUSDP/E 111.4
IDXX
IDEXX Laboratories, Inc.
$41.58BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
GH
Guardant Health, Inc.
$25.12BUSD
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc.
$17.32BUSDP/E 36.4
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ERF
Eurofins Scientific SE
$14.05BUSDP/E 26.2
ICLR
ICON Public Limited Company
$12.99BUSDP/E 177.2
BIM
bioMérieux S.A.
$10.02BUSDP/E 20.0
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2
GRAL
GRAIL, Inc.
$6.88BUSD

Key Statistics

Company
Market Cap25.03B USD
Enterprise Value31.72B USD
Revenue (TTM)14.35B USD
Gross Profit4.01B USD
Net Income (TTM)876.50M USD
Revenue/Share174.02 USD
Last Price311.28 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees71.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)25.53
P/E (Forward)15.55
PEG1.20
EV/EBITDA13.67
EV/Revenue2.21
P/S1.74
P/B2.90
EPS (TTM)12.09
EPS (Forward)19.84
52W Range
244.5269% of range341.80
52W High341.80 USD
52W Low244.52 USD
Profitability
Gross Margin28.76%
Oper. Margin12.24%
EBITDA Margin16.17%
Profit Margin6.28%
ROE10.17%
ROA4.77%
Growth
Revenue Growth5.80%
Earnings Growth28.20%
Cash Flow & Leverage
Operating CF1.64B USD
CapEx (TTM)434.50M USD
FCF Margin6.22%
FCF Yield3.56%
Net Debt6.68B USD
Net Debt/EBITDA2.88
Balance Sheet
Debt/Equity0.76
Current Ratio1.80
Quick Ratio1.25
Book Value/Sh106.39 USD
Cash/Share1.75 USD
Dividends
Fwd Div Rate2.88 USD
Trail. Div Rate2.88 USD
Div. Yield0.93%
5Y Avg Yield0.96%
Payout Ratio23.82%
Ex-Div DateAug 28, 2026
Pay DateSep 11, 2026
Splits
Last Split1164:1000
Split DateJul 3, 2023
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)344.81 USD
Upside (mean)+10.8%
Target Range293.00 USD – 385.00 USD
293.00+10.8% to mean385.00
# Analysts16
Ownership
Shares Out.81.10M
Float80.72M
Insiders0.35%
Institutions101.86%
Short Interest
Short Ratio3.5d
Short % Float3.03%
Short % Out.3.02%
Shares Short2.45M
Short (prev mo.)1.94M
Technical
SMA 50319.35 (-2.5%)
SMA 200280.35 (+11.0%)
Beta0.85
S&P 52W Chg14.58%
Avg Vol (30d)753.85K
Avg Vol (10d)809.66K
Technical Indicators
RSI (14)43.3
MACD-3.4102
MACD Signal-2.3666
MACD Hist.-1.0436
BB Upper328.14 USD
BB Middle313.75 USD
BB Lower299.36 USD
BB Width9.17%
ATR (14)6.832 USD
Vol Ratio (20d)0.83x